Alcedo Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 25-12-2024
- Paid Up Capital ₹ 4.90 Cr
as on 25-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 65.69 Cr
as on 25-12-2024
- Revenue -14.16%
(FY 2022)
- Profit -98.83%
(FY 2022)
- Ebitda -13.04%
(FY 2022)
- Net Worth 0.79%
(FY 2022)
- Total Assets 10.40%
(FY 2022)
About Alcedo Pharmachem
The Corporate was formerly known as Amarox Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 4.90 Cr.
The company currently has active open charges totaling ₹65.69 Cr.
Rajeswari Kottamanchi, Ravindranath Meka, Mettu Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2016PTC111056
- Company No.
111056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alcedo Pharmachem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeswari Kottamanchi  | Director | 10-Mar-2018 | Current |
| Ravindranath Meka | Whole-Time Director | 02-Nov-2018 | Current |
| Mettu Reddy | Director | 01-Mar-2018 | Current |
| Spoorthi Kambam | Director | 01-Feb-2018 | Current |
Financial Performance of Alcedo Pharmachem.
Alcedo Pharmachem Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.16% decrease. The company also saw a substantial fall in profitability, with a 98.83% decrease in profit. The company's net worth moved up by a moderate rise of 0.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alcedo Pharmachem?
In 2023, Alcedo Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gaudium Educational Services Private LimitedActive 11 years 5 monthsSpoorthi Kambam is a mutual person
Greenmark Housing Private LimitedActive 5 years 4 monthsRajeswari Kottamanchi and Spoorthi Kambam are mutual person
Rare Seals Pharmapack LlpActive 1 year 10 monthsRajeswari Kottamanchi and Spoorthi Kambam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jun 2024 | ₹13.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2023 | ₹1.41 M | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2023 | ₹1.41 M | Open |
How Many Employees Work at Alcedo Pharmachem?
Alcedo Pharmachem has a workforce of 65 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alcedo Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alcedo Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
